These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 23863119)

  • 21. [Fertility preservation in breast cancer patients: the state of art in 2014?].
    Comtet M; Sonigo C; Valdelièvre C; Sermondade N; Sifer C; Grynberg M
    Bull Cancer; 2015 May; 102(5):443-53. PubMed ID: 25739327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.
    Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL
    Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Aromatase Inhibitors in IVF for Fertility Preservation of Non-Breast Cancer Patients: A Case Series.
    Ben-Haroush A; Ben-Aharon I; Lande Y; Fisch B
    Isr Med Assoc J; 2018 Mar; 20(3):145-146. PubMed ID: 29527850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes†.
    Pereira N; Hancock K; Cordeiro CN; Lekovich JP; Schattman GL; Rosenwaks Z
    Gynecol Endocrinol; 2016 Oct; 32(10):823-826. PubMed ID: 27114051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fertility after breast cancer treatment.
    Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome.
    Casper RF; Mitwally MF
    Clin Obstet Gynecol; 2011 Dec; 54(4):685-95. PubMed ID: 22031258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fertility preservation with ovarian stimulation protocols prior to cancer treatment.
    Kasum M; Šimunić V; Orešković S; Beketić-Orešković L
    Gynecol Endocrinol; 2014 Mar; 30(3):182-6. PubMed ID: 24256369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients.
    Turan V; Bedoschi G; Moy F; Oktay K
    Fertil Steril; 2013 Dec; 100(6):1681-5.e1. PubMed ID: 24055050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
    Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
    Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Random-start ovarian stimulation in patients with cancer.
    Cakmak H; Rosen MP
    Curr Opin Obstet Gynecol; 2015 Jun; 27(3):215-21. PubMed ID: 25919235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Random-start controlled ovarian hyperstimulation with letrozole for fertility preservation in cancer patients: case series and review of literature.
    Keskin U; Ercan CM; Yilmaz A; Babacan A; Korkmaz C; Duru NK; Ergun A
    J Pak Med Assoc; 2014 Jul; 64(7):830-2. PubMed ID: 25255597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letrozole and gonadotropins versus luteal estradiol and gonadotropin-releasing hormone antagonist protocol in women with a prior low response to ovarian stimulation.
    Elassar A; Engmann L; Nulsen J; Benadiva C
    Fertil Steril; 2011 Jun; 95(7):2330-4. PubMed ID: 21514582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation.
    Almog B; Azem F; Gordon D; Pauzner D; Amit A; Barkan G; Levin I
    Fertil Steril; 2012 Oct; 98(4):957-60. PubMed ID: 22763097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.
    Mitwally MF; Casper RF
    J Soc Gynecol Investig; 2004 Sep; 11(6):406-15. PubMed ID: 15350255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
    Chaudhury K; Chaudhury S; Khastgir G; Purakaystha S
    J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fertility preserving methods in women with breast cancer before gonadotoxic therapy].
    Halászová N; Crha I; Huser M; Weinberger V; Žáková J; Ješeta M; Lousová E; Filipinská E; Ventruba P
    Ceska Gynekol; 2017; 82(4):287-292. PubMed ID: 28925272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized controlled trial comparing superovulation with letrozole versus recombinant follicle-stimulating hormone combined with intrauterine insemination for couples with unexplained infertility who had failed clomiphene citrate stimulation and intrauterine insemination.
    Gregoriou O; Vlahos NF; Konidaris S; Papadias K; Botsis D; Creatsas GK
    Fertil Steril; 2008 Sep; 90(3):678-83. PubMed ID: 17961561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depot GnRH-agonist trigger for breast-cancer patient undergoing ovarian stimulation resulted in mature oocytes for cryopreservation: a case report.
    Cavagna M; Dzik A
    Reprod Biomed Online; 2011 Mar; 22(3):317-9. PubMed ID: 21273128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.
    Mohsen IA; El Din RE
    Gynecol Endocrinol; 2013 Feb; 29(2):105-8. PubMed ID: 23134528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-dose administration of an aromatase inhibitor for ovarian stimulation.
    Mitwally MF; Casper RF
    Fertil Steril; 2005 Jan; 83(1):229-31. PubMed ID: 15652918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.